1,035
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Sirolimus plus gemcitabine: a new therapeutic combination for resistant sarcomas?

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Juan Martin-Liberal, Ezequiel Pérez & Xavier García Del Muro. (2019) Investigational therapies in phase II clinical trials for the treatment of soft tissue sarcoma. Expert Opinion on Investigational Drugs 28:1, pages 39-50.
Read now

Articles from other publishers (3)

Elise F. Nassif, Cissimol P. Joseph, Rossana Lazcano, Jocelyn T. Joseph, Prapassorn Thirasastr, Alexander J. Lazar & Neeta Somaiah. (2023) Case report: Responses to the combination of gemcitabine with sirolimus in two patients with TSC-mutated sarcomas. Frontiers in Oncology 13.
Crossref
Amelia-Naomi Sabo, Sarah Jannier, Guillaume Becker, Jean-Marc Lessinger, Natacha Entz-Werlé & Véronique Kemmel. (2021) Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology. Pharmaceutics 13:4, pages 470.
Crossref
Hua Chen, Jacson Shen, Edwin Choy, Francis J. Hornicek & Zhenfeng Duan. (2016) Targeting protein kinases to reverse multidrug resistance in sarcoma. Cancer Treatment Reviews 43, pages 8-18.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.